文献速递关节外科

含抑肽酶的纤维蛋白封闭剂不能减少全髋关节置换术中的失血量

An Aprotinin Containing Fibrin Sealant Does Not Reduce Blood Loss in Total Hip Arthroplasty.
PubMed 文献 · J Arthroplasty · 2017-05-31

该回顾性队列研究比较了三组各80例初次全髋关节置换术患者:使用含抑肽酶的纤维蛋白封闭剂TISSEEL组、静脉注射1 g氨甲环酸(TXA)组和未使用两者对照组。结果显示TISSEEL组术后最低血红蛋白显著低于TXA组(P=0.021),血红蛋白下降幅度大于TXA组(P=0.029)和对照组(P=0.036),输血率高于TXA组(P=0.002),与对照组无差异(P=0.375)。结论认为TISSEEL不能减少术后失血或输血,推荐使用TXA减少围手术期失血。

要点

  • TISSEEL组术后最低血红蛋白显著低于TXA组(P=0.021),与对照组无差异(P=0.134)。
  • TISSEEL组血红蛋白下降幅度大于TXA组(P=0.029)和对照组(P=0.036)。
  • TISSEEL组输血率与对照组无差异(P=0.375),但显著高于TXA组(P=0.002)。

核心结论

  • TISSEEL纤维蛋白封闭剂不能减少全髋关节置换术后的失血或输血。
  • 静脉注射TXA较TISSEEL和对照组减少术后输血。
  • 推荐使用TXA减少围手术期失血,纤维蛋白封闭剂需进一步改进后才用于全髋关节置换术常规。

研究设计与样本

  • 回顾性均匀队列研究,从前瞻性维护的数据库中识别初次全髋关节置换术病例。
  • 三组各80例:TISSEEL组、静脉注射1 g TXA组、未使用两者对照组。
  • 结局指标包括术后住院期间最低血红蛋白、术前至术后血红蛋白最大下降值及输血率。

主要发现

  • TISSEEL组术后最低血红蛋白显著低于TXA组(P=0.021),与对照组无差异(P=0.134)。
  • TISSEEL组血红蛋白下降幅度大于TXA组(P=0.029)和对照组(P=0.036)。
  • TISSEEL组输血率与对照组无差异(P=0.375),显著高于TXA组(P=0.002)。

临床怎么用

  • 作者推荐使用TXA减少围手术期失血。
  • 作者认为纤维蛋白封闭剂需进一步改进后才用于全髋关节置换术常规。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Fibrin sealants are topical agents used to reduce perioperative blood loss; however, their efficacy in total hip arthroplasty (THA) remains uncertain. The purpose of this study was to determine if a fibrin sealant containing aprotinin as an antifibrinolytic agent, TISSEEL (Baxter, Deerfield, IL), reduces postoperative blood loss and transfusion during THA when compared with intravenous (IV) tranexamic acid (TXA) and control groups. METHODS: Three retrospective uniform cohorts of primary THA procedures were identified, from a prospectively maintained database: 1 group who received TISSEEL, 1 group who received 1 g IV TXA, and 1 group who received neither (control). There were 80 patients in each group. Outcome measures included the lowest measured hemoglobin during postoperative hospitalization, greatest decrease in hemoglobin from preoperative to postoperative values, and blood transfusion rates. RESULTS: The minimum postoperative hemoglobin level was significantly lower for TISSEEL patients compared with that of IV TXA patients (P = .021) and no different when compared with that of control patients (P = .134). Patients receiving fibrin sealant had a greater hemoglobin level decrease compared with that of IV TXA (P = .029) and control (P = .036). Postoperative transfusion rates were no different for the group receiving TISSEEL compared with those of control (P = .375) and were statistically greater when compared with those of IV TXA (P = .002). CONCLUSION: TISSEEL fibrin sealant does not reduce postoperative blood loss or transfusions; however, IV TXA reduced postoperative transfusions compared with TISSEEL and control. Therefore, TXA is recommended to reduce perioperative blood loss, while, utilization of a fibrin sealant requires further refinements before being adopted for routine use in THA.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Kearns SM, Kuhar HN, Bohl DD, et al. An Aprotinin Containing Fibrin Sealant Does Not Reduce Blood Loss in Total Hip Arthroplasty. J Arthroplasty. 2017. PMID: 28648705. doi:10.1016/j.arth.2017.05.040

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。